Nitrazepam, a benzodiazepine belonging to the group of tranquilizers, is primarily prescribed for the short-term management of severe insomnia. This powerful compound works by reducing the central nervous system, promoting relaxation and facilitating slumber. While remarkably effective in inducing drowsiness, nitrazepam carries important risks and

Ibogaine therapy is steadily gaining traction in the European Union , with a growing number of individuals seeking this unconventional approach to address opioid addiction and other mental health challenges. Innovative clinics are appearing across the continent, offering carefully structured ibogaine-assisted treatment programs. While legal framew